Contact us Demo our platform

Metabolon @

EAAP 2025 – 76th Annual Meeting of the European Federation of Animal Science

Dates: 25th – 29th August 2025
Location: Innsbruck, Austria
Event Website: eaap2025.org

Join Metabolon at EAAP 2025

Metabolon is excited to attend the 76th Annual Meeting of the European Federation of Animal Science (EAAP 2025), taking place in Innsbruck, Austria. This premier international gathering of animal scientists, researchers, and industry stakeholders provides a critical platform for discussing innovations across animal genetics, physiology, nutrition, sustainability, and production systems.

As delegates at this year’s EAAP, Nina Goerner and Simone de Faria Maraschin from Metabolon will be engaging with attendees, exploring how metabolomics can offer valuable insights into animal health, feed efficiency, and precision breeding strategies.

We look forward to joining collaborative sessions, scientific discussions, and networking events aimed at shaping the future of animal science.

Key Themes at EAAP 2025

EAAP 2025 will address a broad range of scientific and industry topics under the unifying theme of “Future-proof livestock farming”. Notable areas of focus include:

  • Sustainability and Resilience in Livestock Systems
  • Animal Health and Welfare
  • Animal Genetics
  • Advanced Genomics and Breeding Strategies
  • Precision Livestock Farming and Smart Technologies
  • Nutrition and Gut Health
  • Climate Change and Environmental Impact Mitigation

Metabolomics is an essential thread running through these themes, offering a powerful means of connecting genetics, nutrition, health, and the environment. By uncovering metabolic signatures at the phenotype level, it informs genetic selection, optimizes nutritional strategies, enhances animal health monitoring, and supports data-driven sustainability efforts. See more information on the Proposed Sessions – The 76th EAAP Annual Meeting

The Role of Metabolomics in Animal Science

Metabolomics offers a systems-level lens to interpret the biochemical impact of nutrition, genetics, environment, and disease in livestock and companion animals. By measuring thousands of metabolites in biological samples, it enables:

  • Deeper understanding of nutrient utilization and feed efficiency
  • Biomarker discovery for health, stress, and productivity
  • Optimization of breeding through phenotype-driven insights
  • Microbiome-host interaction studies and metabolic adaptation
  • Translational insights from animal models to human health

Find out more:

EAAP 2025 offers a diverse and interdisciplinary scientific program that addresses the most pressing challenges and innovations in animal science:

  • Genetics & Breeding Innovation: Exploring genetic strategies to improve sustainability, animal health, and adaptation.
  • Animal Nutrition & Metabolic Health: Innovations in nutrition science for performance, sustainability, and food quality.
  • Health, Welfare & Disease Management: Advancing welfare and health across species and production systems.
  • Precision Livestock Farming (PLF) & Digital Tools: Harnessing data and tech to transform livestock production
  • Species-Specific Advances: Pigs & Poultry; Ruminants (Cattle, Sheep, Goats); Equine Science.
  • Livestock Systems, Sustainability & Climate: Systems-based approaches for resilient and eco-friendly farming.
  • Physiology, Microbiome & Holobiont Science: Integrating microbial and host biology to understand systemic function.
  • Insects & Circular Agriculture: Exploring the future of insects in food and feed systems.

Why Connect with Metabolon at EAAP 2025?

Why Metabolon?

With 25 years of scientific expertise, over 4,000 publications, more than 15,000 completed projects, and the world’s largest curated metabolite reference library (with more than 5,400 level 1 and level 2 annotated metabolites), Metabolon is the global leader in metabolomics.

Built on high-resolution mass spectrometry and rigorous quality controls, our platform delivers accurate, quantitative metabolite data across species and matrices.

To maximize the value of metabolomic data, we provide an Integrated Bioinformatics Platform that brings together metabolomics with genomics, transcriptomics, and other omics data. Designed for collaboration and with advanced statistical tools, interactive visualizations, and machine learning capabilities, researchers can generate system-wide insights that support evidence-based livestock science and policy.

We’re looking forward to meaningful conversations at EAAP about how metabolomics can support:

  • Feed formulation and performance optimization
  • Understanding genetic traits via metabolic phenotyping
  • Enhancing resilience to climate or pathogenic stressors
  • Improving animal welfare outcomes

Don’t stay behind – incorporate high-quality metabolomics analysis in your project. Book a meeting with Nina and Simone by filling the form on this page!

In the meantime, feel free to explore how Metabolon supports research in livestock, aquaculture, and veterinary medicine:

Meet the Metabolon’s Team at EAAP 2025

Our team attending EAAP 2025 will include scientific experts and business development leads with deep experience in metabolomics and translational applications.

Nina Goerner, Business Development Director, Southern Europe & ROW
Nina has more than 10 years of experience working at Metabolon and is currently Metabolon’s business development director for Southern Europe & ROW. She holds a PhD in structural biology by FU Berlin and the IRB in Barcelona where she applied NMR and mass spectrometry for structural elucidation of protein domains. She then gained experience in targeted and untargeted metabolomics working in the industry as well as in academia as scientific manager in nutritional metabolomics. She enjoys scientific consultative activities helping clients to advance their research by applying Metabolon’s unique metabolomic solutions. Nina is excited about new advances, especially in nutrition, microbiology and animal health.

Simoné de Faria Maraschin, Director International Sales.
Simoné currently leads the International Sales Team at Metabolon, supporting Metabolon’s customers throughout EMEA and APAC regions. She holds a PhD in Molecular and Cell Biology by Leiden University, The Netherlands. She has worked for more than 15 years for the Agrifood and Lifesciences industry, where she led different research departments. After her MBA in 2016, she has been fully dedicated to providing pre-clinical and clinical research solutions to academic and industrial customers. She is passionate about product innovation and client satisfaction. Simone is based in Tours, France.

Let’s connect in Innsbruck and discuss how metabolomics can support your goals – book a meeting with Nina and Simone using the form on this page.

Learn More About EAAP 2025

Schedule a Meeting

Latest Resources

Access a wealth of valuable resources to deepen your understanding about metabolomics and the scientific advancements it has empowered.

✕

References

1. Zgoda-Pols, J.R., et al., Metabolomics analysis reveals elevation of 3-indoxyl sulfate in plasma and brain during chemically-induced acute kidney injury in mice: investigation of nicotinic acid receptor agonists. Toxicol Appl Pharmacol, 2011. 255(1): p. 48-56.

2. Bryant, J.A., et al., The impact of an oral purified microbiome therapeutic on the gastrointestinal microbiome. Nat Med, 2026. 32(1): p. 186-196

3. McGovern, B .H., et al., SER-109, an Investigational Microbiome Drugto Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial. Clin Infect Dis, 2021. 72(12): p. 2132-2140.

4. Feuerstadt, P., et al., SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection. N Engl J Med, 2022. 386(3): p. 220-229.

5. Hu, Z., et al., Targeted metabolomics reveals novel diagnostic biomarkers for colorectal cancer. Mol Oncol, 2025. 19(6): p. 1737-1750.

6. Butler, F.M., et al., Vegetarian Dietary Patterns and Diet-Related Metabolites Are Associated With Kidney Function in the Adventist Health Study-2 Cohort. J Ren Nutr, 2025.

7. Stanford, J., et al., Metabolomic Profiling and Diet Quality Scoring in a Randomized Crossover Trial of Healthy and Typical Dietary Patterns. Mol Nutr Food Res, 2025 . 69(23): p. e70271.

8. O’Connor, L.E., et al., Metabolomic Profiling of an Ultraprocessed Dietary Pattern in a Domiciled Randomized Controlled Crossover Feeding Trial. J Nutr, 2023. 153(8): p. 2181-2192.

9. Fritsch, D.A., et al., Microbiome function underpins the efficacy of a fiber-supplemented dietary intervention in dogs with chronic large bowel diarrhea. BMC Vet Res, 2022. 18(1): p. 245.

10. Leal, L.N., et al., Preweaning nutrient supply improves lactation productivity and reduces the risk of culling in Holstein cows. J Dairy Sci, 2025. 108(6): p. 5875-5888.

11. Ahsin, M., et al., Soil and pasture health underlie improved beef nutrient density determined by untargeted metabolomics in Southern US grass finished beef systems. NPJ Sci Food, 2025. 9(1): p. 151.

12. Yin, W., et al., Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia. J Lipid Res, 2012. 53(1): p. 51-65.

13. Porter, F .D., et al., Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease. Sci Transl Med, 2010. 2(56): p. 56ra81.

14. Needham, B .D., et al., Plasma and Fecal Metabolite Profiles in Autism Spectrum Disorder. Biol Psychiatry, 2021. 89(5): p. 451-462

15. Li, C., et al., Estradiol and mTORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cells. J Exp Med, 2014. 211(1): p. 15-28.

16. Green, P.G., et al., Metabolic flexibility and reverse remodelling of the failing human heart. Eur Heart J, 2025. 46(25): p. 2422-2433.

17. Maekawa, H., et al., SGLT2 inhibition protects kidney function by SAM-dependent epigenetic repression of inflammatory genes under metabolic stress. J Clin Invest, 2025. 135(19).

18. Wu, D., et al., Integrated screens reveal that guanine nucleotide depletion, which is irreversible via targeting IMPDH2, inhibits pancreatic cancer and potentiates KRAS inhibition. Gut, 2026.

19. Schwerdtfeger, L.A., et al., Gut microbiota and metabolites are linked to disease progression in multiple sclerosis. Cell Rep Med, 2025. 6(4): p. 102055.

20. Wu, H., et al., Microbiome-metabolome dynamics associated with impaired glucose control and responses to lifestyle changes. Nat Med, 2025. 31(7): p. 2222-2231.

21. Jacobs, J.P., et al., Cognitive behavioral therapy for irritable bowel syndrome induces bidirectional alterations in the brain-gut-microbiome axis associated with gastrointestinal symptom improvement. Microbiome, 2021. 9(1): p. 236.

22. Pietzner, M., et al., Plasma metabolites to profile pathways in noncommunicable disease multimorbidity. Nat Med, 2021. 27(3): p. 471-479.

23. Faquih, T.O., et al., Robust Metabolomic Age Prediction Based on a Wide Selection of Metabolites. J Gerontol A Biol Sci Med Sci, 2025. 80(3).

24. Scherer, N., et al., Coupling metabolomics and exome sequencing reveals graded effects of rare damaging heterozygous variants on gene function and human traits. Nat Genet, 2025. 57(1): p. 193-205.

25. Holmes, Z.C., et al., Untargeted metabolomic analysis of human milk from healthy mothers reveals drivers of metabolite variability. Sci Rep, 2024. 14(1): p. 20827.

26. Titz, B., et al., Implications of Ocular Confounding Factors for Aqueous Humor Proteomic and Metabolomic Analyses in Retinal Diseases. Transl Vis Sci Technol, 2024. 13(6): p. 17.

27. Bloom, S.M., et al., Cysteine dependence of Lactobacillus iners is a potential therapeutic target for vaginal microbiota modulation. Nat Microbiol, 2022. 7(3): p. 434-450.

28. Leimer, E.M., et al., Lipid profile of human synovial fluid following intra-articular ankle fracture. J Orthop Res, 2017. 35(3): p. 657-666.